Thanks for that… I knew this development would eventually happen, it makes sense. It won’t help speed all new drugs to market, but ones which are already approved for different uses (which physicians can prescribe off-label, but pharma companies can’t manufacture and market for a new use), this will help things a lot.
For instance, Dr. Cotsarelis’ setipiprant, which is a PGD2 inhibitor already approved for other indications. If this bill passes and is signed into law, it could conceivably bring a special formulation of setipiprant for hair loss to market almost IMMEDIATELY.